SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Changes

25 Sep 2025 07:00

RNS Number : 6929A
Porvair PLC
25 September 2025
 

 

For immediate release 25 September 2025

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Board Changes

Lisa Anson

Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025.

Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI).

Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland.

On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair.

Porvair confirms that there are no further matters in relation to Lisa Anson's appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.

Sally Martin

Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025.

Sheena Mackay

Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

Andrew Douglass, Group Company Secretary

 

Burson Buchanan

+44 (0)207 466 5000

Charles Ryland / Stephanie Whitmore

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEZLFLEKLZBBF
Date   Source Headline
7th Apr 20097:00 amRNSAGM/Interim Management Stmt
20th Mar 20095:30 pmRNSHolding(s) in Company
16th Feb 20093:27 pmRNSHolding(s) in Company
3rd Feb 20093:31 pmRNSHolding(s) in Company
3rd Feb 20093:13 pmRNSHolding(s) in Company
2nd Feb 20094:40 pmRNSHolding(s) in Company
2nd Feb 20094:29 pmRNSHolding(s) in Company
27th Jan 20097:00 amRNSPreliminary Results
21st Jan 200910:50 amRNSHolding(s) in Company
10th Dec 20087:00 amRNSTrading update
2nd Dec 20082:54 pmRNSHolding(s) in Company
17th Oct 20087:00 amRNSInterim Management Statement
1st Sep 200812:00 pmRNSTotal Voting Rights
15th Aug 20086:29 pmRNSHolding(s) in Company
15th Aug 20086:15 pmRNSHolding(s) in Company
31st Jul 20084:14 pmRNSIssue of Equity
30th Jul 200812:24 pmRNSHolding(s) in Company
9th Jul 20087:00 amRNSAcquisition of Seal
1st Jul 20083:49 pmRNSHolding(s) in Company
24th Jun 20087:00 amRNSInterim Results
4th Jun 20087:00 amRNSTrading Statement
23rd May 20083:35 pmRNSHolding(s) in Company
19th May 20084:15 pmRNSDirector/PDMR Shareholding
19th May 200812:17 pmRNSDirector/PDMR Shareholding
29th Apr 20084:36 pmRNSHolding(s) in Company
9th Apr 20084:00 pmRNSResult of AGM
9th Apr 20087:00 amRNSAGM/Interim Management Stmt
1st Apr 20087:00 amRNSAcquisition
31st Mar 20088:00 amRNSTotal Voting Rights
26th Mar 20081:00 pmRNSAnnual Information Update
19th Mar 20087:00 amRNSBlocklisting Interim Review
11th Mar 20083:20 pmRNSFiling of Documents
5th Mar 20087:01 amRNSContract Wins
27th Feb 20087:01 amRNSParticipation in EU Project
29th Jan 20087:05 amRNSRe Agreement
29th Jan 20087:00 amRNSPreliminary Results
19th Dec 20074:46 pmRNSHolding(s) in Company
10th Dec 200711:56 amRNSHolding(s) in Company
10th Dec 20077:00 amRNSTrading Statement
2nd Oct 200711:35 amRNSLease of larger factory
2nd Oct 200711:27 amRNSDirectorate Change
2nd Oct 20078:44 amRNSDirector/PDMR Shareholding
31st Jul 20079:32 amRNSTotal Voting Rights
30th Jul 200711:00 amRNSDirector/PDMR Shareholding
26th Jun 20077:02 amRNSInterim Results
15th Jun 20078:00 amRNSAdditional Listing
6th Jun 20077:00 amRNSTrading Update
5th Jun 200711:28 amRNSAnnual Information Update
31st May 20071:10 pmRNSNotice of Results
18th Apr 20071:04 pmRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.